NEFL and Alzheimer disease: Recently, robust studies have shown that NfL level in the peripheral blood is a promising biomarker for tracking neurodegenerative changes in patients with AD and increased levels are related to brain atrophy, brain hypometabolism, and decreased cognitive function (Zetterberg et al., 2016; Mattsson et al., 2017; Mayeli et al., 2019).